These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37494029)

  • 41. Development of a clinical Scandinavian registry for hidradenitis suppurativa; HISREG.
    Ingvarsson G; Dufour DN; Killasli H; Sartorius K; Lapins J; Skau PA; Moseng D; Dinparvar D; Furberg AS; Jemec GB; Emtestam L
    Acta Derm Venereol; 2013 May; 93(3):350-1. PubMed ID: 23093212
    [No Abstract]   [Full Text] [Related]  

  • 42. Hidradenitis Suppurativa in the Military.
    Godiwalla RY; Storie EB; Winn AE
    Cutis; 2020 Oct; 106(4):181-184. PubMed ID: 33186426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidisciplinary approach for hidradenitis suppurativa patients.
    Veraldi S; Guanziroli E; Benzecry V; Nazzaro G
    G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):18-19. PubMed ID: 30468376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expert Knowledge, Attitudes, and Practices in Management of Hidradenitis Suppurativa Pain.
    Jedrzejczak MJ; Ingram JR; Lowes MA; Naik HB; McKenzie-Brown AM; Chen SC; Orenstein LAV
    JAMA Dermatol; 2021 Apr; 157(4):464-466. PubMed ID: 33625467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moving toward structured, specialized hidradenitis suppurativa care to improve patient outcomes.
    Kearney N; Kirby B
    Br J Dermatol; 2023 Aug; 189(3):e57-e58. PubMed ID: 37317955
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hidradenitis suppurativa/acne inversa: An update].
    Kirschke J; Hessam S; Bechara FG
    Hautarzt; 2015 Jun; 66(6):413-22. PubMed ID: 25877488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hidradenitis Suppurativa.
    Alikhan A
    JAMA Dermatol; 2016 Jun; 152(6):736. PubMed ID: 27276356
    [No Abstract]   [Full Text] [Related]  

  • 48. Managing seasonal flares in hidradenitis suppurativa.
    Atluri S; Masson R; Tran K; Hsiao JL; Shi VY
    J Am Acad Dermatol; 2024 Jan; 90(1):e23-e24. PubMed ID: 37716369
    [No Abstract]   [Full Text] [Related]  

  • 49. Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices.
    Fottorino A; Richard MA; Prouteau C; Balland C; Villani AP; Buche S; Hotz C; Delage M; Nassif A; Cogrel O; Jouan N
    Ann Dermatol Venereol; 2023 Sep; 150(3):227-229. PubMed ID: 36894389
    [No Abstract]   [Full Text] [Related]  

  • 50. Hidradenitis Suppurativa: New Opportunities for an Orphan Skin Disease.
    Carrascosa JM; Bassas J; Puig L
    Actas Dermosifiliogr; 2015; 106(6):448-51. PubMed ID: 25796270
    [No Abstract]   [Full Text] [Related]  

  • 51. Hidradenitis Suppurativa: The Disease Which Stimulates Researchers and Clinicians.
    Szepietowski JC; Matusiak Ł
    Dermatology; 2020; 236(1):5-7. PubMed ID: 31955165
    [No Abstract]   [Full Text] [Related]  

  • 52. Assessing Psychological Interventions for Hidradenitis Suppurativa as a First Step Toward Patient-Centered Practice.
    Misitzis A; Katoulis A
    Cutis; 2021 Mar; 107(3):123-124. PubMed ID: 33956602
    [No Abstract]   [Full Text] [Related]  

  • 53. Hidradenitis suppurativa.
    Danby FW; Margesson LJ
    Dermatol Clin; 2010 Oct; 28(4):779-93. PubMed ID: 20883920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: An update.
    Li X; Jiang L; Huang Y; Ren Z; Liang X; Wang P
    Australas J Dermatol; 2020 Feb; 61(1):e10-e14. PubMed ID: 31266094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive approach to managing hidradenitis suppurativa patients.
    Collier EK; Hsiao JL; Shi VY; Naik HB
    Int J Dermatol; 2020 Jun; 59(6):744-747. PubMed ID: 32250448
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical Pearls for Managing Hidradenitis Suppurativa Patients of Low Socioeconomic Status.
    McKenzie SA; Lev-Tov HA; Shi VY; Hsiao JL
    Dermatology; 2020; 236(5):439-444. PubMed ID: 31927547
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of a patient-reported outcome questionnaire to assess signs and symptoms of hidradenitis suppurativa: The Hidradenitis Suppurativa Symptom Diary.
    Alavi A; Baradaran S; Mathias SD; Colwell HH; Song M; Hamzavi IH; Han C
    J Am Acad Dermatol; 2023 May; 88(5):1123-1125. PubMed ID: 34808326
    [No Abstract]   [Full Text] [Related]  

  • 58. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa].
    Kirsten N; Frings V; Nikolakis GD; Presser D; Goebeler M; Zouboulis CC; Augustin M
    Hautarzt; 2021 Aug; 72(8):651-657. PubMed ID: 34223939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.